Ardelyx discovers, develops, and commercializes innovative medicines to address significant unmet medical needs, with two commercial products in the U.S., IBSRELA® and XPHOZAH®. They have international agreements for tenapanor, including partnerships with Kyowa Kirin in Japan, Fosun Pharma in China, and Knight Therapeutics in Canada.
